v3.25.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net (loss) income $ (15,138) $ 13,521
Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities:    
Depreciation and amortization 8,879 7,210
Bad debt provision 73,381 36,643
Deferred income taxes (15,180) (3,485)
Share-based compensation expense 6,279 4,597
Amortization of premium on marketable securities 235 795
Unrealized gain on deferred compensation fund investments (3,195) (5,388)
Changes in other long-term liabilities (384) (334)
Net loss on disposals of property and equipment 161 405
Share of losses from equity method investment (2,379) 0
Changes in operating assets and liabilities:    
Accounts and notes receivable (15,759) (48,056)
Inventories and supplies (607) 623
Prepaid expenses and other assets 843 (3,491)
Deferred compensation funding 715 157
Accounts payable and other accrued expenses (10,887) (15,695)
Accrued payroll, accrued and withheld payroll taxes 15,665 1,862
Deferred ERC credits 20,016 0
Income taxes payable (7,003) (2,921)
Accrued insurance claims (1,605) (1,576)
Deferred compensation liability 2,251 5,419
Net cash provided by (used in) operating activities 56,288 (9,714)
Cash flows from investing activities:    
Disposals of property and equipment 76 150
Additions to property and equipment (3,102) (3,510)
Cash paid for acquisition (7,287) 0
Cash paid for investments (2,125) (2,750)
Purchases of marketable securities (4,611) (37,880)
Sales of marketable securities 229 27,951
Net cash used in investing activities (16,820) (16,039)
Cash flows from financing activities:    
Purchases of treasury stock (14,711) (3,000)
Proceeds from short-term borrowings 0 5,000
Payments of statutory withholding on net issuance of restricted stock units (1,744) (1,030)
Net cash (used in) provided by financing activities (16,455) 970
Net increase (decrease) in cash, cash equivalents and restricted cash equivalents 23,013 (24,783)
Cash, cash equivalents and restricted cash equivalents at beginning of the period 60,131 54,330
Cash, cash equivalents and restricted cash equivalents at end of the period $ 83,144 $ 29,547